Direct Answer
Digital cognitive screeners in primary care are short cognitive tests delivered on a tablet or computer that a patient often completes before or during a routine visit. The device presents standardized tasks, scores responses automatically, and flags whether a closer look at memory and thinking may be warranted. They are screening tools that a clinician interprets in context — not a diagnosis — and they are increasingly used to make brief cognitive checks more consistent and less time-consuming in a busy practice.
Why It Matters
Cognitive change is common with age, yet it is frequently missed in exactly the setting where it should first surface. An estimated 7.4 million Americans age 65 and older are living with Alzheimer's in 2026, and half of primary care physicians report that they do not feel adequately prepared to care for people with Alzheimer's and other dementias (Alzheimer's Association, 2026). Detection lags as a result: even though annual cognitive screening is meant to catch early problems, fewer than half of cases are identified in primary care (Wallace et al., 2025).
Part of the gap is practical. A typical primary care appointment is short, and administering and scoring a paper test by hand takes time a clinician may not have. Digital screeners aim to close that gap by moving the routine, standardized part of the check onto a device the patient can use themselves. For a broader look at the technology behind these products, see our overview of digital cognitive assessment.
What a Digital Screener Actually Is
A digital cognitive screener is a brief, structured assessment — usually a handful of tasks that sample memory, attention, and processing speed — delivered through an app or web browser. It differs from a full diagnostic evaluation in three important ways:
- It is brief. Most are designed to run in roughly 5 to 15 minutes, not hours.
- It is often self-administered. Many are built so the patient can complete them with little or no staff help.
- It produces a flag, not a label. The output is a score that signals whether further evaluation is worth considering, which a clinician then interprets.
These tools sit alongside — not in place of — the familiar brief paper screens a clinician may still use. For a wider survey of the categories and how they compare, see our guide to digital cognitive assessment tools.
How Primary Care Practices Use Them
In practice, digital screeners are usually folded into the flow of a visit rather than added as a separate appointment. A common model is to hand the patient a tablet during the rooming process — the intake steps a medical assistant handles before the clinician comes in — so the screen is finished by the time the visit begins. Some practices go a step further and let patients complete a screen at home in the days before the appointment.
Two examples from published research illustrate the approach. The MyCog system is a tablet app self-administered in person during rooming, studied across real primary care clinics (Wallace et al., 2025). The Cleveland Clinic Cognitive Battery, or C3B, is a self-administered, iPad-based battery designed specifically for efficient screening of older adults in primary care, taking about 10 minutes to complete (Kabeshita et al., 2023). In both cases, the goal is the same: gather standardized information consistently, without consuming scarce clinician time.
The Medicare Connection
A major reason cognitive screening happens in primary care at all is Medicare. The yearly Wellness visit — a preventive benefit that people with Medicare Part B pay nothing for when their provider accepts assignment — directs providers to "perform a cognitive assessment to look for signs of dementia, including Alzheimer's disease," and if the clinician suspects a problem, Medicare covers a separate, more thorough visit to evaluate cognition and check for conditions like depression or delirium (Medicare.gov, 2026). That follow-up evaluation, and any other services added during the visit that aren't covered under the preventive benefit, may carry the usual Part B coinsurance and deductible. Digital screeners are one efficient way to carry out that first assessment. If you want the details of how this fits into a typical appointment, our guide to cognitive screening at the annual wellness visit walks through it.
What the Evidence Shows
The evidence for self-administered digital screening in primary care is encouraging, with important caveats. In validation work, the C3B achieved high completion rates among primary care patients and distinguished mild cognitive impairment from healthy aging, outperforming a commonly used brief paper screen (Kabeshita et al., 2023). Real-world adoption is more uneven: in the MyCog primary care study, overall completion during rooming was modest and varied widely from clinic to clinic, reflecting the practical realities of workflow, staffing, and patient comfort with technology (Wallace et al., 2025).
Two lessons follow. First, a tool's performance in a study does not guarantee smooth adoption in every clinic. Second, screening should be purposeful. The U.S. Preventive Services Task Force concluded that current evidence is insufficient to recommend routine screening of all older adults who have no symptoms, which is a reminder that these tools are most valuable when there is a real reason to look closer (U.S. Preventive Services Task Force, 2020).
When to Consider One
A digital cognitive screen can be a sensible step when you or a family member has noticed changes in memory or thinking, when you want an objective baseline to compare against later, or when your clinician recommends one as part of a Wellness visit. It is not a substitute for a full evaluation, and a single score should never be read as a verdict. If a tool carries FDA clearance, that signals it has met a reviewed evidence standard; our guide to what makes a cognitive test FDA-cleared explains what that label does and does not mean.
What Happens Next
Whatever screen is used, the result is the start of a conversation, not the end of one. A clinician interprets the score alongside your medical history, medications, mood, sleep, and other health factors, and orders further evaluation only if it is warranted. Many causes of cognitive change are treatable, so an unexpected result is a reason to ask questions rather than to assume the worst.
Taking the Next Step
To understand the broader technology these screens are built on, read our overview of digital cognitive assessment.
If you would like a validated, FDA-cleared screen you can complete from home and share with your doctor, see how Orena's at-home test works.
Frequently asked questions
What is a digital cognitive screener in primary care?
Does Medicare cover cognitive screening in primary care?
Are digital cognitive screeners accurate enough for primary care?
Should every older adult be screened?
Sources
- Digital Cognitive Screening in Primary Care: Feasibility, Acceptability, and Usability of the MyCog Measurement System — Alzheimer's & Dementia, 2025
- Cleveland Clinic Cognitive Battery (C3B): Normative, Reliability, and Validation Studies of a Self-Administered Computerized Tool for Screening Cognitive Dysfunction in Primary Care — Journal of Alzheimer's Disease, 2023
- Yearly 'Wellness' Visits — Medicare.gov, 2026
- Cognitive Impairment in Older Adults: Screening — U.S. Preventive Services Task Force, 2020
- 2026 Alzheimer's Disease Facts and Figures — Alzheimer's Association, 2026
Medical disclaimer. This article is for general educational purposes and is not a substitute for professional medical or insurance advice. Orena does not diagnose Alzheimer’s or dementia from a test alone. Always consult your doctor about your specific situation.



